Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
26.88
+0.62 (2.36%)
Nov 14, 2024, 4:00 PM EST - Market closed
Tourmaline Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -63.88 | -42.12 | -19.7 | -0.9 |
| Depreciation & Amortization | 0.04 | 0.03 | 0.01 | - |
| Asset Writedown & Restructuring Costs | - | 8.82 | 12.13 | - |
| Loss (Gain) From Sale of Investments | -6.25 | -0.54 | - | - |
| Stock-Based Compensation | 9.11 | 5.77 | 0.2 | - |
| Other Operating Activities | 0.13 | 0.12 | 0.02 | - |
| Change in Accounts Payable | 0.39 | -0.04 | 0.19 | 0.78 |
| Change in Other Net Operating Assets | -5.27 | -0.12 | 0.71 | 0.13 |
| Operating Cash Flow | -65.73 | -28.08 | -6.46 | - |
| Capital Expenditures | -0 | -0.06 | -0.07 | - |
| Sale (Purchase) of Intangibles | - | - | -5 | - |
| Investment in Securities | -206.8 | 3.9 | - | - |
| Investing Cash Flow | -206.8 | 3.84 | -5.07 | - |
| Short-Term Debt Issued | - | - | 0.25 | - |
| Total Debt Issued | - | - | 0.25 | 0.6 |
| Short-Term Debt Repaid | - | - | -0.4 | - |
| Total Debt Repaid | - | - | -0.4 | - |
| Net Debt Issued (Repaid) | - | - | -0.15 | 0.6 |
| Issuance of Common Stock | 161.35 | 0.14 | - | - |
| Other Financing Activities | 68.14 | 64.75 | - | - |
| Financing Cash Flow | 229.49 | 156.72 | 19.85 | 0.6 |
| Net Cash Flow | -43.04 | 132.48 | 8.32 | 0.6 |
| Free Cash Flow | -65.73 | -28.14 | -6.53 | - |
| Free Cash Flow Per Share | -2.87 | -5.93 | -7.44 | - |
| Levered Free Cash Flow | -47.55 | -24.92 | -16.26 | - |
| Unlevered Free Cash Flow | -47.55 | -24.92 | -16.26 | - |
| Change in Net Working Capital | 7.44 | 2.29 | -0.92 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.